W

West Houston Area Clinical Trial Consultants | Wichita, KS

Research site

(Unclaimed)

Location

3535 N Webb rd, Wichita, Kansas, United States of America

Site insights

Top conditions

Top treatments

BI 690517

Obicetrapib

Empagliflozin

Parent organization

This site is a part of West Houston Area Clinical Trial Consultants

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Study to Test Whether BI 690517 in Combination With Empagliflozin Helps People With Heart Failure

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left...

Enrolling

Heart Failure

Drug: Empagliflozin

Drug: BI 690517

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT (BACKBEAT)

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval m...

Enrolling

Hypertension

Hypertension, Essential

Device: Medtronic Astra/Azure DR MRI IPG with AVIM therapy Deactivated

Device: Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Drug: Obicetrapib

Drug: Placebo

Trial sponsors

N

O

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms